Up to 12,000 men are dying from prostate cancer in England each year because they are denied groundbreaking drugs on the NHS, charities warn
Up to 12,000 men are dying from prostate cancer in England each year because they are denied groundbreaking drugs on the NHS, charities warn.
Three charities have united with actor Stephen Fry, who survived the disease, to call for precision treatments Olaparib and Pluvicto to be made available.
Olaparib is the world’s first genetically targeted drug to be proven safe and effective for advanced prostate cancer for men with the BRCA 1/2 mutation.
1 in 4 Black men will get prostate cancer, like I did. It’s time for government to make life-extending drug available.
I WAS diagnosed with prostate cancer back in 2021, and I know what it feels like to have your time threatened by a serious illness.
In 2020, I had a slightly raised PSA result and was told to keep an eye on it and come back again in 12 months.
A year later, I was getting a bit sore, having ridden a static bike in the gym for around six months, and I started having more trips to the toilet at night, as well as having more urgency when I needed to go.